While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

Ligufalimab is under clinical development by Akeso and currently in Phase II for Head And Neck Squamous Cell Carcinoma (HNSC).

CTX-471 is under clinical development by Compass Therapeutics and currently in Phase I for Head And Neck Cancer.

While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

Bone-strengthening drugs for cancer are now available. They can help treat cancer that has spread to the bones (bone metastasis), which is quite common. In many cases, they can be used as soon as bone ...

Metastasis is when cancer spreads beyond the place where it started to other areas of body. Nearly all cancers have the potential to metastasize. #medindia #cancer #metastasis’ More than half of ...

Head and neck cancer comprises a group of biologically similar cancers that start in the lip, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx and larynx.

In 2015, a person with metastatic melanoma — a form ... including lung cancer, breast cancer, endometrial cancer, head and neck cancer and some rare forms of colon cancer. Studies of its ...

Drinking coffee and tea might reduce the risk of developing head and neck cancers, including cancers of the mouth and throat, according to recent research. Scientists at the University of Utah's ...